BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 15671091)

  • 1. Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.
    Zendran I; Gut G; Kałużny M; Zawadzka K; Bolanowski M
    Front Endocrinol (Lausanne); 2022; 13():867965. PubMed ID: 35757397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids.
    Gagliardi I; Tarquini M; Ambrosio MR; Giannetta E; Borges de Souza P; Gafà R; Carnevale A; Franceschetti P; Zatelli MC
    Front Endocrinol (Lausanne); 2020; 11():621557. PubMed ID: 33628200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?
    Bresciani G; Ditsiou A; Cilibrasi C; Vella V; Rea F; Schiavon M; Cavallesco NG; Giamas G; Zatelli MC; Gagliano T
    Endocr Connect; 2019 Jun; 8(6):680-690. PubMed ID: 31035254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When should genetic testing be performed in patients with neuroendocrine tumours?
    O'Shea T; Druce M
    Rev Endocr Metab Disord; 2017 Dec; 18(4):499-515. PubMed ID: 28965289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiothoracic manifestations of neuroendocrine tumours.
    Mandegaran R; David S; Screaton N
    Br J Radiol; 2016; 89(1060):20150787. PubMed ID: 26781701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
    Beckers A; Lodish MB; Trivellin G; Rostomyan L; Lee M; Faucz FR; Yuan B; Choong CS; Caberg JH; Verrua E; Naves LA; Cheetham TD; Young J; Lysy PA; Petrossians P; Cotterill A; Shah NS; Metzger D; Castermans E; Ambrosio MR; Villa C; Strebkova N; Mazerkina N; Gaillard S; Barra GB; Casulari LA; Neggers SJ; Salvatori R; Jaffrain-Rea ML; Zacharin M; Santamaria BL; Zacharieva S; Lim EM; Mantovani G; Zatelli MC; Collins MT; Bonneville JF; Quezado M; Chittiboina P; Oldfield EH; Bours V; Liu P; W de Herder W; Pellegata N; Lupski JR; Daly AF; Stratakis CA
    Endocr Relat Cancer; 2015 Jun; 22(3):353-67. PubMed ID: 25712922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magmas overexpression inhibits staurosporine induced apoptosis in rat pituitary adenoma cell lines.
    Tagliati F; Gagliano T; Gentilin E; Minoia M; Molè D; Delgi Uberti EC; Zatelli MC
    PLoS One; 2013; 8(9):e75194. PubMed ID: 24069394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the use of somatostatin analogs in oncology.
    Keskin O; Yalcin S
    Onco Targets Ther; 2013; 6():471-83. PubMed ID: 23667314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic acromegaly due to growth hormone releasing hormone.
    Ghazi AA; Amirbaigloo A; Dezfooli AA; Saadat N; Ghazi S; Pourafkari M; Tirgari F; Dhall D; Bannykh S; Melmed S; Cooper O
    Endocrine; 2013 Apr; 43(2):293-302. PubMed ID: 22983831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.
    Butler PW; Cochran CS; Merino MJ; Nguyen DM; Schrump DS; Gorden P
    Pituitary; 2012 Jun; 15(2):260-5. PubMed ID: 20379782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results.
    Colak Ozbey N; Kapran Y; Bozbora A; Erbil Y; Tascioglu C; Asa SL
    Endocr Pathol; 2009; 20(2):127-32. PubMed ID: 19301154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma.
    Verrua E; Ronchi CL; Ferrante E; Ferrari DI; Bergamaschi S; Ferrero S; Zatelli MC; Branca V; Spada A; Beck-Peccoz P; Lania AG
    Pituitary; 2010 Sep; 13(3):289-92. PubMed ID: 18946740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.
    Biermasz NR; Smit JW; Pereira AM; Frölich M; Romijn JA; Roelfsema F
    Pituitary; 2007; 10(3):237-49. PubMed ID: 17541749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
    Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
    Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogs in vitro effects in a growth hormone-releasing hormone-secreting bronchial carcinoid.
    Zatelli MC; Maffei P; Piccin D; Martini C; Rea F; Rubello D; Margutti A; Culler MD; Sicolo N; degli Uberti EC
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2104-9. PubMed ID: 15671091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
    van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
    J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro.
    Zatelli MC; Piccin D; Bondanelli M; Tagliati F; De Carlo E; Culler MD; Uberti EC
    Horm Metab Res; 2003 Jun; 35(6):349-54. PubMed ID: 12920656
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.